Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch
Executive Summary
Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law